Editorial: Epigenetics and genomic causality in development and chromatin research
Open Access
- 7 February 2025
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Epigenetics and Epigenomics
- Vol. 3, 1564074
Abstract
Pasadena, CA 91125 USA and 2 Jacques Loeb Centre for the History and Philosophy of Science, Ben-Gurion University of the Negev, Beer Sheva, Israel.The term "epigenetic" has had its meaning change substantially since it was proposed over 80 years ago (see, e.g., Morange 2002;Felsenfeld 2014;Deichmann 2016;Greally 2018).Originally conceived broadly as the set of processes that generate phenotype from genotype over time in development (Waddington 1942), it is currently used to mean the mechanisms demarcating different parts of the genome for differential gene activity in a given cellular context. We now have a highly sophisticated mechanistic understanding of the ways different genomic regions are marked by histone modification, DNA methylation, and chromatin remodelling in concert with differential local gene expression or local gene silencing. Other aspects of epigenetics include formation of dynamic protein condensates, chromatin looping, and shifts in intranuclear gene localization.All these epigenetic mechanisms themselves depend, directly or indirectly, on the activities of genes that encode chromatin modifying enzymes, and they gain their target-gene specificity by the trans-acting, sequence-specific transcription factors and regulatory RNAs, which guide the chromatin modifiers to specific genomic locations. Of particular interest is the reciprocal way that transcription factors and chromatin epigenetic states affect each other's action; sequence-specific transcription factor action is crucial to change gene expression for developmental progression, while chromatin states channel transcription factor activity and help to make development irreversible. This collection reveals some historical foundations of current chromatin research, and highlights the connection between events that are now called epigenetic, the genomic loci that encode epigenetic regulators, and the regulatory factors that guide them in development in different systems. It includes sophisticated case studies drawn from hematopoiesis, and an evaluation of the claims for epigenetic mechanisms in transgenerational inheritance in mammals.Deichmann (https://www.frontiersin.org/articles/10.3389/freae.2023.1334556/full) summarizes in-depth historical interviews with two pioneers of the field, Gary Felsenfeld and Sir Adrian Bird. Felsenfeld, who passed away at the beginning of May 2024, was a leader in many aspects of chromatin structural analysis. He specifically demonstrated the power of differential chromatin accessibility to identify active regulatory elements in the genome and investigated control of chromatin looping, the critical process that enables distal enhancers to interact with the correct promoters. Bird has long been a leader in the field of DNA methylation on CpG dinucleotides and their regulatory impact. This was one of the earliest-appreciated epigenetic marks, which first illustrated many of the paradigmatic aspects of epigenetic marking mechanisms in general. His work has revealed that a neurological disease, Rett syndrome, is caused by a mutation altering levels of a methyl-CpG binding protein that is an epigenetic modifier. As he noted, though: this syndrome is caused by mutations that change the DNA sequence. The primary change is the DNA sequence, and the secondary consequences are the epigenetic changes. It is thus an excellent example of the fact that genetics and epigenetics are closely linked. Some of the most sophisticated work on epigenetic causality has been carried out in hematopoietic systems. Even before the sequencing of mouse and human genomes, intense work was already under way to determine the epigenetic mechanisms that control highlyspecific expression of the genes that encode immunoglobulins in B cells and T-cell receptors in T cells (Nelsen et al. 1993;Stanhope-Baker et al. 1996;Nikolajczyk et al. 1999;Bergman et al. 2003;Cobb et al. 2006). This head start established these immunoreceptor loci as, arguably, the parts of the mammalian genome where epigenetic control is the best understood, as reviewed by Ma et al. (https://doi.org/10.3389/freae.2024.1489362 ).These loci undergo highly cell type-specific DNA-level rearrangement in development as well as transcriptional activation. However, the chromatin structures, enhancers, transcription factors that work on the enhancers, and impacts of enhancer mutations on transcription in the correct lineages at the correct developmental times have been defined functionally in all of these loci with exceptional clarity, setting precedents that have subsequently proven to be of much wider generality. These genes continue to provide important insights: they include strong evidence for transcription factor combinatorial action and multiple well-demonstrated cases of temporal mismatches between chromatin opening and enhancer activation leading to transcription. These imply that additional levels of regulation still need to be explained.Hematopoiesis more broadly has also been subjected to intense study to relate epigenetic mechanisms to developmentally controlled, lineage-specific cell type identity (e.g., Zeller et al. 2023;Yoshida et al. 2019;Goode et al. 2016;Javierre et al. 2016;Gonzalez et al. 2015).The research paper by Maytum et al.(https://www.frontiersin.org/articles/10.3389/freae.2024.1465958/full) takes a genomewide view of the epigenomic transformations that accompany the earliest emergence of hematopoiesis. The DNA sequences in regions of chromatin undergoing epigenetic change give evidence that sequence-specific factors of the AP-1 transcription factor family, which normally become active in cells responding to acute signaling, are involved in opening chromatin at specific sites marking different developmental pathways. A paradox is that AP-1 is not cell type-specific; how can it guide distinct patterns of epigenomic change for different cell types? The authors present evidence that AP-1 gains distinct target site specificities...Keywords
This publication has 16 references indexed in Scilit:
- The cis-Regulatory Atlas of the Mouse Immune SystemCell, 2019
- A user's guide to the ambiguous word 'epigenetics'Nature Reviews Molecular Cell Biology, 2018
- Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene PromotersCell, 2016
- Epigenetics: The origins and evolution of a fashionable topicDevelopmental Biology, 2016
- Dynamic Gene Regulatory Networks Drive Hematopoietic Specification and DifferentiationDevelopmental Cell, 2016
- Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiationNature Genetics, 2015
- Accessibility Control of V(D)J Recombination2006
- Epigenetic mechanisms that regulate antigen receptor gene expressionCurrent Opinion in Immunology, 2003
- ETS Protein–Dependent Accessibility Changes at the Immunoglobulin μ Heavy Chain EnhancerImmunity, 1999
- Cell Type–Specific Chromatin Structure Determines the Targeting of V(D)J Recombinase Activity In VitroCell, 1996